Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Linlin Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8692-3663; OpenAlex author ID A5054869868. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Glutamine addiction and therapeutic strategies in pancreatic cancer. Co-author DOI 10.4251/wjgo.v15.i11.1852↗
  2. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.5939↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongyun Wei · 1 shared paper, 2023 · strength 0.22
  2. Zibin Tian · 1 shared paper, 2023 · strength 0.22
  3. Jie Hong · 1 shared paper, 2015 · strength 0.05
  4. Tingting Yan · 1 shared paper, 2015 · strength 0.05
  5. Xueliang Fu · 1 shared paper, 2015 · strength 0.05
  6. Yongwei Sun · 1 shared paper, 2015 · strength 0.05
  7. Dejun Liu · 1 shared paper, 2015 · strength 0.05
  8. Rong Hua · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.